Evaluation of a new beta-adrenergic blocking agent, carteolol, based on metabolic responses in rats-I. Blockade in vivo of epinephrine- and isoproterenol-induced alterations of blood concentrations of carbohydrate and lipid intermediary metabolites.
D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000818:Animals; D002241:Carbohydrates / Q000097:blood*; D004837:Epinephrine / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D006493:Heparin / Q000494:pharmacology; D007211:Indoles / Q000494:pharmacology; D007328:Insulin / Q000378:metabolism; D007545:Isoproterenol / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D002040:Levobunolol / Q000494:pharmacology*; D008055:Lipids / Q000097:blood*; D008297:Male; D051381:Rats; D013268:Stimulation, Chemical
D002241:Carbohydrates; D007211:Indoles; D007328:Insulin; D008055:Lipids; D000324:Adrenocorticotropic Hormone; D006493:Heparin; D002040:Levobunolol; D007545:Isoproterenol; D004837:Epinephrine